NO-REFLOW PHENOMENON
Clinical trials for NO-REFLOW PHENOMENON explained in plain language.
Never miss a new study
Get alerted when new NO-REFLOW PHENOMENON trials appear
Sign up with your email to follow new studies for NO-REFLOW PHENOMENON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy may fix slow blood flow after heart attack stenting
Disease control Not yet recruitingThis study tests whether adding the blood thinner rivaroxaban to standard aspirin and clopidogrel can improve sluggish blood flow in heart attack patients who just had a stent placed. About 60 adults will receive either the triple therapy or standard dual therapy for one month. R…
Matched conditions: NO-REFLOW PHENOMENON
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Insulin resistance may predict poor blood flow after heart attack stenting in diabetics
Knowledge-focused Not yet recruitingThis study investigates whether insulin resistance, measured by the TyG index, is linked to the no-reflow phenomenon—where blood flow fails to restore properly—after primary PCI (stenting) for heart attacks in people with type 2 diabetes. Researchers will also examine how insulin…
Matched conditions: NO-REFLOW PHENOMENON
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC